6533b822fe1ef96bd127d655

RESEARCH PRODUCT

The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS

Rafael López-blanchSoraya L. VallesElena ObradorAli Jihad-jebbarRosario Salvador PalmerJosé M. Estrela

subject

BioenergeticsQH301-705.5Calcium bufferingredox statusReviewMitochondrionmedicine.disease_causebioenergeticsCatalysisInorganic ChemistryMitophagymedicineAnimalsHumansoxidative stressPhysical and Theoretical ChemistryAmyotrophic lateral sclerosisBiology (General)Molecular BiologyQD1-999SpectroscopyMotor Neuronschemistry.chemical_classificationReactive oxygen speciesbusiness.industryAmyotrophic Lateral SclerosisOrganic ChemistryGeneral Medicinemedicine.diseaseComputer Science ApplicationsmitochondriaChemistrychemistryAxoplasmic transportALSEnergy MetabolismbusinessOxidation-ReductionNeuroscienceOxidative stress

description

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease of the motor system. It is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and paralysis. ALS is incurable and has a bleak prognosis, with median survival of 3–5 years after the initial symptomatology. In ALS, motor neurons gradually degenerate and die. Many features of mitochondrial dysfunction are manifested in neurodegenerative diseases, including ALS. Mitochondria have shown to be an early target in ALS pathophysiology and contribute to disease progression. Disruption of their axonal transport, excessive generation of reactive oxygen species, disruption of the mitochondrial structure, dynamics, mitophagy, energy production, calcium buffering and apoptotic triggering have all been directly involved in disease pathogenesis and extensively reported in ALS patients and animal model systems. Alterations in energy production by motor neurons, which severely limit their survival capacity, are tightly linked to the redox status and mitochondria. The present review focuses on this link. Placing oxidative stress as a main pathophysiological mechanism, the molecular interactions and metabolic flows involved are analyzed. This leads to discussing potential therapeutic approaches targeting mitochondrial biology to slow disease progression.

10.3390/ijms22126352https://www.mdpi.com/1422-0067/22/12/6352